Anandamide suppresses pain initiation through a peripheral endocannabinoid mechanism
Jason R. Clapper(Amplyx Pharmaceuticals (United States)), Daniele Piomelli(University of California, Irvine), Roberto Russo(University of Naples Federico II), Guillermo Moreno‐Sanz(Universidad Complutense de Madrid), Natale R. Sciolino(University of Georgia), Antonio Calignano(University of Naples Federico II), Andrea Duranti(Université de Montréal), Federica Vacondio(University of Parma), Andrea Tontini(Université de Montréal), Ana Guijarro(University of Genoa), Jessica Marie Spradley(Colorado Blood Cancer Institute), Giorgio Tarzia(Université de Montréal), Marco Mor(University of Parma), Silvano Sanchini(University of Montana), Andrea G. Hohmann(Indiana University Bloomington)
Cited by 348
Related Papers
Antidepressant-like activity and modulation of brain monoaminergic transmission by blockade of anandamide hydrolysis
|Proceedings of the National Academy of Sciences|2005|677
Diet-induced mouse model of fatty liver disease and nonalcoholic steatohepatitis reflecting clinical disease progression and methods of assessment
|American Journal of Physiology-Gastrointestinal and Liver Physiology|2013|294
Dopamine activation of the arachidonic acid cascade as a basis for D1D2 receptor synergism
|Nature|1991|261
Anxiolytic-Like Properties of the Anandamide Transport Inhibitor AM404
|Neuropsychopharmacology|2006|228